SCHEMBL5773323

SCHEMBL5773323

O=C1Nc2cc(Br)ccc2C1=Cc1cc(Br)c(O)c(Br)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 10/20 0.73
MAP1LC3B Q9GZQ8 3/20 0.70
LRRK2 Q5S007 3/20 0.64
SIRT1 Q96EB6 3/20 0.64
SIRT2 Q8IXJ6 2/20 0.64
SIRT3 Q9NTG7 2/20 0.64
PLK4 O00444 2/20 0.64
PSEN1 P49768 1/20 0.64
PSEN2 P49810 1/20 0.64
APH1B Q8WW43 1/20 0.64
NCSTN Q92542 1/20 0.64
APH1A Q96BI3 1/20 0.64
PSENEN Q9NZ42 1/20 0.64
EGFR P00533 1/20 0.64
NTRK1 P04629 1/20 0.64
ARAF P10398 1/20 0.64
PIM1 P11309 1/20 0.64
BRAF P15056 1/20 0.64
CSNK2A1 P68400 1/20 0.64
PIM3 Q86V86 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980521 1.00 RAF1 (0.73) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5774039 0.89 MAP1LC3B (0.88) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5774043 0.89 MAP1LC3B (0.88) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL3754416 0.89 MAP1LC3B (0.88) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5772003 0.86 PLK4 (0.65) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5771999 0.86 PLK4 (0.65) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL3571033 0.86 MAP1LC3B (0.67) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL3571032 0.86 MAP1LC3B (0.67) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5771850 0.85 RAF1 (0.68) RAF1MAP1LC3BLRRK2SIRT1SIRT2
SCHEMBL5771851 0.85 RAF1 (0.68) RAF1MAP1LC3BLRRK2SIRT1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003721-B1 BENZYLIDENE-1,3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS, PARTICULARLY OF RAF KINASES GLAXO GROUP LTD (GB) 2006-11-02 EP disclosed
WO-2004069998-A2 OXINDOLE DERIVATIVES AS ANTIMICROBIAL AGENTS ARROW THERAPEUTICS LIMITED (GB) 2004-08-19 WO disclosed
US-6268391-B1 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases GLAXO WELLCOME INC. 2001-07-31 US disclosed